New Updates For Intravenous Immune Globulin (IVIG)
The updates are intended for suppliers submitting claims to Durable Medical Equipment Medicare Administrative Contractors (DME MACs) for Intravenous Immune Globulin (IVIG) drugs and services for Medicare beneficiaries. In general, suppliers do not need to apply to participate in the demonstration as long as they meet all Medicare as well as other national, state, and local standards and regulations applicable to the provision of demonstration covered services. The Centers for Medicare & Medicaid Services (CMS) informs providers that a new Medicare contractor, Noridian Healthcare Solutions, LLC, will replace NHIC as the implementation support contractor for the Intravenous Immune Globulin (IVIG) demonstration as of July 1, 2016. This article also reminds suppliers of the 2016 payment rate for demonstration service code Q2052. The 2016 payment rate is $336.05. As of June 2016, Medicare is continuing to accept applications from beneficiaries on a rolling basis. This will continue as long as the funding or enrollment limitations are not reached or until the demonstration ends, whichever occurs sooner. As of June 24th, applications should no longer be submitted to NHIC. The last date to submit an application for coverage prior to September 30, 2017 (when the demonstration is scheduled to end) is August 15, 2017.
The CMS provides a complete overview of the IVIG demonstration. Part of the overview includes a discussion of how beneficiaries need to submit an application in order to participate in the demonstration. As of June 24, 2016, such applications must be submitted to Noridian Healthcare Solutions, LLC.